Skip to content

A study to compare effectiveness and tolerability of Bimatoprost and Timolol eye drops in Open Angle Glaucoma.

A Comparative Study Of Efficacy And Safety Of Bimatoprost And Timolol In Patients With Primary Open Angle Glaucoma.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044079
Enrollment
70
Registered
2022-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H401- Open-angle glaucoma

Interventions

Intervention1: Bimatoprost (0.03%) eyedrop: Bimatoprost (0.03%) one drop OD at 8 pm on the affected eye/eyes for 8 weeks Control Intervention1: Timolol (0.5%) eyedrop: Timolol (0.5%) one drop twice da

Sponsors

Dr Sreyanwita Mukherjee
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Age: 18 to 60 years of age of either sex. Patients with newly diagnosed, drug naive, primary open angle glaucoma patients of either sex attending the Department of Ophthalmology OPD at College of Medicine & Sagore Dutta Hospital, Kamarhati, Kolkata. • Patient who will give the written informed consent form voluntarily and are available during the entire study duration.

Exclusion criteria

Exclusion criteria: • Pregnant or lactating women. • Patients who are suffering from other congenital glaucoma secondary to other ophthalmic conditions. • Patient who has undergone any kind of medical and surgical treatment in the past. • Patient who has undergone corrective refractive surgery. • Patients with uncontrolled Hypertension, Diabetes mellitus. • Patients receiving chemotherapy for Malignancy. • Patients having infection in one or both eyes within the last three months. • Patients having ocular injury within last three months. • Patients suffering from major systemic illness or features of severe systemic infection are excluded from the study.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of the two drugs, Bimatoprost and Timolol in terms of reduction of intraocular pressure for the treatment of Primary Open Angle Glaucoma from baseline visit, visit at fourth weeks and upto eight weeks.Timepoint: At baseline visit, visit at fourth weeks and eight weeks.

Secondary

MeasureTime frame
To compare the safety of the two drugs, Bimatoprost and Timolol in terms of adverse effect for the treatment of Primary Open Angle Glaucoma from base line visit, visit at fourth weeks, upto visit at eight weeks.Timepoint: At baseline visit, visit at fourth weeks and eight weeks.

Countries

India

Contacts

Public ContactDr Prithwijit Banerjee

College of Medicine and Sagore Dutta Hospital Kamarhati Kolkata West Bengal PIN 700058

drprithwijit@gmail.com9830500513

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026